DK1789067T3 - Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet - Google Patents

Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet

Info

Publication number
DK1789067T3
DK1789067T3 DK05786631.1T DK05786631T DK1789067T3 DK 1789067 T3 DK1789067 T3 DK 1789067T3 DK 05786631 T DK05786631 T DK 05786631T DK 1789067 T3 DK1789067 T3 DK 1789067T3
Authority
DK
Denmark
Prior art keywords
growth hormone
gastrointestinal motility
hormone secretion
stimulate gastrointestinal
inducers
Prior art date
Application number
DK05786631.1T
Other languages
English (en)
Inventor
Wiliam J Polvino
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Application granted granted Critical
Publication of DK1789067T3 publication Critical patent/DK1789067T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05786631.1T 2004-08-12 2005-08-12 Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet DK1789067T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60095904P 2004-08-12 2004-08-12
PCT/US2005/028851 WO2006020930A2 (en) 2004-08-12 2005-08-12 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues

Publications (1)

Publication Number Publication Date
DK1789067T3 true DK1789067T3 (da) 2012-08-27

Family

ID=35908211

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05786631.1T DK1789067T3 (da) 2004-08-12 2005-08-12 Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet

Country Status (17)

Country Link
US (3) US20070191283A1 (da)
EP (1) EP1789067B8 (da)
JP (1) JP2008509930A (da)
KR (2) KR20130048793A (da)
CN (1) CN101076349B (da)
AU (1) AU2005272598B2 (da)
CA (1) CA2576238C (da)
CY (1) CY1113067T1 (da)
DK (1) DK1789067T3 (da)
ES (1) ES2388501T3 (da)
HK (1) HK1105279A1 (da)
IL (1) IL181249A (da)
MX (1) MX2007001477A (da)
PL (1) PL1789067T3 (da)
PT (1) PT1789067E (da)
SI (1) SI1789067T1 (da)
WO (1) WO2006020930A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039456B2 (en) * 2004-08-12 2011-10-18 Helsinn Therapeutics (U.S.), Inc. Method of stimulating the motility of the gastrointestinal system using ipamorelin
KR20130048793A (ko) * 2004-08-12 2013-05-10 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을 촉진하는 방법
EP2389941A1 (en) * 2004-08-18 2011-11-30 Elixir Pharmaceuticals, Inc. Growth-hormone secretagogues
CA2625447C (en) * 2005-09-29 2015-06-09 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Compositions and methods for stimulating gastrointestinal motility
US8088733B2 (en) * 2006-07-06 2012-01-03 Tranzyme Pharma Inc. Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
EP2952522B1 (en) 2007-01-31 2019-10-30 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
MX2009008574A (es) 2007-02-09 2009-12-09 Tranzyme Pharma Inc Moduladores del receptor de grelina macrociclicos y metodos para usar el mismo.
KR101623985B1 (ko) 2007-03-28 2016-05-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
AU2008341160A1 (en) * 2007-12-21 2009-07-02 Helsinn Therapeutics (U.S.), Inc. Method of stimulating the motility of the gastrointestinal system using ipamorelin
AU2009246543B2 (en) * 2008-05-13 2015-08-06 Clarassance, Inc. Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis
WO2010009380A2 (en) 2008-07-18 2010-01-21 Trinity Therapeutics, Inc. Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
JP5889506B2 (ja) * 2008-09-12 2016-03-22 丸善製薬株式会社 毛乳頭細胞増殖促進剤
UA105657C2 (uk) * 2009-02-27 2014-06-10 Хелсінн Терапьютікс (Ю.Ес.), Інк. Поліпшені способи лікування мігрені на основі анамореліну
CN102812037A (zh) 2009-10-30 2012-12-05 特兰齐姆制药公司 大环生长素释放肽受体拮抗剂和反向激动剂及其使用方法
WO2012021876A2 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
TWI643868B (zh) 2011-10-18 2018-12-11 艾利倫治療公司 擬肽巨環化合物
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
EP2822572B1 (en) 2012-02-15 2020-06-10 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
EP2914256B1 (en) 2012-11-01 2019-07-31 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
CA3178035A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
DK2956440T3 (da) 2013-02-08 2018-05-28 Gen Mills Inc Næringsmiddelprodukter med reduceret natriumindhold
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
JP6539274B2 (ja) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 押出成形された即放性乱用抑止性丸剤
EP3060250A1 (en) 2013-10-22 2016-08-31 NovImmune SA Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
CN106999541A (zh) 2014-09-24 2017-08-01 艾瑞朗医疗公司 拟肽大环化合物及其用途
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
MX2017011834A (es) 2015-03-20 2018-04-11 Aileron Therapeutics Inc Macrociclos peptidomimeticos y usos de los mismos.
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
CN111643501A (zh) * 2020-04-27 2020-09-11 长春金赛药业有限责任公司 Gensci073或其类似物的用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0622717B1 (en) * 1993-04-30 1998-12-30 STMicroelectronics S.r.l. Temperature stable circuit for recycling discharge current during the driving of an inductive load
US5434171A (en) * 1993-12-08 1995-07-18 Eli Lilly And Company Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
US5767085A (en) * 1993-12-23 1998-06-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
IL124702A0 (en) * 1995-12-22 1998-12-06 Novo Nordisk As Compounds with growth hormone releasing properties
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
JP4425992B2 (ja) * 1996-07-22 2010-03-03 サファイア セラピューティクス，インコーポレイティド 成長ホルモン放出特性を有する化合物
US6286927B1 (en) * 1997-12-25 2001-09-11 Canon Kabushiki Kaisha Ink jet element substrate and ink jet head that employs the substrate, and ink jet apparatus on which the head is mounted
US6494563B2 (en) * 1997-12-25 2002-12-17 Canon Kabushiki Kaisha Ink jet element substrate and ink jet head that employs the substrate, and ink jet apparatus on which the head is mounted
US6083908A (en) * 1998-01-16 2000-07-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6303620B1 (en) * 1998-05-11 2001-10-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
WO1999058501A1 (en) * 1998-05-11 1999-11-18 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6919315B1 (en) * 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
DK1100824T3 (da) * 1998-06-30 2011-06-20 Helsinn Therapeutics Us Inc Forbindelser med væksthormonfrigivende egenskaber
US6566337B1 (en) * 1998-11-03 2003-05-20 Novo Nordisk A/S Compounds with growth hormone releasing properties
JO2181B1 (en) 1999-04-29 2003-04-23 شركة جانسين فارماسوتيكا ان. في Procalopride solution is taken by mouth
US6451806B2 (en) * 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
UA73530C2 (uk) * 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
US6469030B2 (en) * 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
WO2001056592A1 (en) * 2000-02-01 2001-08-09 Novo Nordisk A/S Use of compounds for the regulation of food intake
EP1159964B1 (en) * 2000-05-31 2009-10-28 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating gastrointestinal motility
IL143942A0 (en) 2000-06-29 2002-04-21 Pfizer Prod Inc Use of growth hormone secretagogues for treatment of physical performance decline
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
US20050277677A1 (en) * 2004-06-10 2005-12-15 Heiman Mark L Method for treating emesis with ghrelin agonists
KR20130048793A (ko) * 2004-08-12 2013-05-10 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을 촉진하는 방법

Also Published As

Publication number Publication date
IL181249A0 (en) 2007-07-04
CY1113067T1 (el) 2016-04-13
CA2576238C (en) 2013-11-12
AU2005272598A1 (en) 2006-02-23
ES2388501T3 (es) 2012-10-16
PL1789067T3 (pl) 2012-10-31
MX2007001477A (es) 2007-10-10
KR101380200B1 (ko) 2014-04-01
US8039457B2 (en) 2011-10-18
CN101076349A (zh) 2007-11-21
AU2005272598B2 (en) 2011-11-17
CN101076349B (zh) 2012-08-22
US20100087381A1 (en) 2010-04-08
IL181249A (en) 2012-02-29
KR20130048793A (ko) 2013-05-10
WO2006020930A3 (en) 2006-11-23
US20070191283A1 (en) 2007-08-16
US20120077745A1 (en) 2012-03-29
PT1789067E (pt) 2012-08-06
SI1789067T1 (sl) 2012-09-28
EP1789067B1 (en) 2012-05-23
EP1789067B8 (en) 2012-08-15
EP1789067A2 (en) 2007-05-30
CA2576238A1 (en) 2006-02-23
EP1789067A4 (en) 2010-09-01
WO2006020930A2 (en) 2006-02-23
KR20070064593A (ko) 2007-06-21
JP2008509930A (ja) 2008-04-03
HK1105279A1 (en) 2008-02-06

Similar Documents

Publication Publication Date Title
DK1789067T3 (da) Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet
LTPA2017004I1 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
DK3050576T3 (da) Pegylerede rekombinante forbindelser af humant væksthormon
DK3187506T3 (da) Antistoffer mod IL-6 og anvendelse deraf
DK2209272T3 (da) Kapacitets-forøgende indretninger og fremgangsmåde til trådløs kommunikation
DK3338799T3 (da) Antistoffer til il-6 og anvendelse deraf
DK1940250T3 (da) Fremgangsmåde til stimulering af tarmfloraen
DE502005000881D1 (de) Knochenverankerungselement
DK1962895T3 (da) TERAPEUTISK ANVENDELSE AF EN Dll4-ANTAGONIST OG EN VEGF-HÆMMER TIL HÆMNING AF TUMORVÆKST
RU2426741C3 (ru) Антагонистические антитела к il-17
DK1646720T3 (da) Antistoffer mod insulinlignende vækstfaktor I-receptor og anvendelser deraf
DK1937262T3 (da) Sammensætning til anvendelse i behandling af gastrointestinal dysmotilitet
DE602007011052D1 (de) Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation
DK1991584T3 (da) Antistoffer mod human IL-22 og anvendelser deraf
DE602004012166D1 (de) Wimpernbehandlungsvorrichtung
DK2124997T3 (da) Anvendelse af IL-1-antagonister til behandling af gigt og pseudogigt
DK1812002T3 (da) Behandling af mastitis
DK1928783T3 (da) Behandling af sulfatrigt calciumoxid
NO20043305D0 (no) Preparation of lodixanol
DK2120570T3 (da) Behandling af præmatur komorbid ejakulation og erektil dysfunktion
EP2133090A4 (en) GROWTH HORMONE SECRETION STIMULATOR
DK1794111T3 (da) Fremgangsmåde til fremstilling af cyclopentanon
DK1768980T3 (da) Forbedret fremgangsmåde til fremstilling af mirtazapin
DK2301576T3 (da) Terapeutisk anvendelse af anti-CS1-antistoffer
EP1740203A4 (en) POLYPEPTIDE INDUCING THE ANGIOPOIETINE SECRETION